Moreover, the complex and heterogenic enzymatic pathway of mTOR and the use of mTOR inhibitors for COPD therapy need a more in-depth knowledge of mTOR signaling (35). This evidence concerns the gene MTOR and chronic obstructive pulmonary disease.